The effect of gene polymorphism on ticagrelor metabolism: an in vitro study of 22 CYP3A4 variants in Chinese Han population
PeerJ · 2024
DOI: 10.7717/peerj.18109 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Xiaoxia Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Jinhua Municipal Central Hospital, Jinhua, China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Ticagrelor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jinhua Science and Technology Bureau of project.
Abstract (Originalsprache)
Background
Ticagrelor is a novel oral antiplatelet agent which can selectively inhibit P2Y12 receptor. Bleeding and dyspnea are common adverse reactions of ticagrelor in clinic. The side effects of ticagrelor are correlated with the plasma concentration of ticagrelor.
Objective
This study aimed to evaluate the catalytic characteristics of 22 CYP3A4 alleles identified in the Chinese Han population on the metabolism of ticagrelor in vitro , focusing on the effect of CYP3A4 polymorphism on ticagrelor metabolism.
Methods
In this study, insect cells were used to express 22 CYP3A4 variants, which were then incubated with 1–50 µM ticagrelor at 37 °C for 30 minutes to obtain the metabolite (AR-C124910XX). AR-C124910XX was detected by UHPLC-MS/MS to calculate the kinetic parameters, including Km, Vmax and CLint.
Results
Compared to the wild-type, most CYP3A4 alleles exhibited significant differences in intrinsic clearance. The intrinsic clearance of CYP3A4*11, *18 and *33 was much higher than that of wild-type; four variants exhibited similar intrinsic clearance values as the wild-type enzyme; The remaining 14 variants showed significantly reduced intrinsic clearance values, ranging from 1.48% to 75.11% of the wild-type; CYP3A4*30 displayed weak or no activity.
Conclusion
This study conducted a comprehensive assessment of the effect of CYP3A4 variants on ticagrelor’s metabolism. The results suggested that there is allele-specific activity towards ticagrelor in vitro . These findings can provide some insights and predictions for treatment strategies and risk assessments associated with ticagrelor in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Jinhua Municipal Central Hospital, Jinhua, China.
- Department of Pharmacy, Jinhua People's Hospital, Jinhua, China.
- Department of Pharmacy, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, China.
- School of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Förderung
- Jinhua Science and Technology Bureau of project
Zitieren
APA
Hu, X., Wang, P., Zeng, D., & Hu, G. X. (2024). The effect of gene polymorphism on ticagrelor metabolism: an in vitro study of 22 CYP3A4 variants in Chinese Han population. PeerJ. https://doi.org/10.7717/peerj.18109
Vancouver
Hu X, Wang P, Zeng D, Hu GX. The effect of gene polymorphism on ticagrelor metabolism: an in vitro study of 22 CYP3A4 variants in Chinese Han population. PeerJ. 2024. doi:10.7717/peerj.18109
BibTeX
@article{Hu2024,
author = {Hu, Xiaoxia and Wang, Peng and Zeng, Dali and Hu, Guo-Xin},
title = {The effect of gene polymorphism on ticagrelor metabolism: an in vitro study of 22 CYP3A4 variants in Chinese Han population},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.18109}
}
EUVIMED